Bioreactor engineering of stem cell environments

Biotechnology Advances

Volumn 31, Issue 7, 2013, Pages 1020-1031

  Tandon, Nina ^a   Marolt, Darja ^b   Cimetta, Elisa ^a   Vunjak Novakovic, Gordana ^a  

^a Columbia University ^*  (United States)

^b New York Stem Cell Foundation   (United States)

Author keywords

Bioengineering; Biomaterials; Bioreactors; High throughput screening; In vitro models; Models of disease; Personalized medicine; Regenerative medicine; Stem cells; Translation

Indexed keywords

CELL BASED THERAPIES; CULTURE SYSTEMS; DRUG SCREENING; HIGH-THROUGHPUT SCREENING; IN-VITRO MODELS; MODERN MEDICINE; PERSONALIZED MEDICINES; REGENERATIVE MEDICINE;

BIOCONVERSION; BIOLOGICAL MATERIALS; BIOMATERIALS; BIOREACTORS; CELL CULTURE; DIAGNOSIS; DISEASE CONTROL; SYSTEMS SCIENCE; TRANSLATION (LANGUAGES);

STEM CELLS;

BIOENGINEERING; BIOREACTOR; CELL ORGANELLE; DISEASE; DRUG; MEDICINE; STEM;

ANIMAL; BIOENGINEERING; BIOLOGICAL MODEL; BIOMATERIALS; BIOREACTOR; CELL ENGINEERING; HIGH THROUGHPUT SCREENING; HIGH-THROUGHPUT SCREENING; HUMAN; IN VITRO MODELS; MODELS OF DISEASE; MOUSE; PERSONALIZED MEDICINE; REGENERATIVE MEDICINE; REVIEW; STEM CELL; STEM CELL NICHE; TRANSLATION;

BIOENGINEERING; BIOMATERIALS; BIOREACTORS; HIGH-THROUGHPUT SCREENING; IN VITRO MODELS; MODELS OF DISEASE; PERSONALIZED MEDICINE; REGENERATIVE MEDICINE; STEM CELLS; TRANSLATION;

ANIMALS; BIOREACTORS; CELL ENGINEERING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICE; MODELS, BIOLOGICAL; REGENERATIVE MEDICINE; STEM CELL NICHE; STEM CELLS;

EID: 84886784880     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.03.007     Document Type: Review

References (141)

1. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008, 26(11):1276-1284.
2. Alfred R., Taiani J.T., Krawetz R.J., Yamashita A., Rancourt D.E., Kallos M.S. Large-scale production of murine embryonic stem cell-derived osteoblasts and chondrocytes on microcarriers in serum-free media. Biomaterials 2011, 32(26):6006-6016.
3. Allen J.W., Bhatia S.N. Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng 2003, 82(3):253-262.
4. Allen J.W., Khetani S.R., Bhatia S.N. In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci 2005, 84(1):110-119.
5. Ananiev G., Williams E., Li H., Chang Q. Isogenic pairs of wild type and mutant iPSc lines from Rett syndrome patients as in vitro disease model. PLoS One 2011, 6(9):e25255.
6. Baker B.M., Shah R.P., Huang A.H., Mauck R.L. Dynamic tensile loading improves the functional properties of mesenchymal stem cell-laden nanofiber-based fibrocartilage. Tissue Eng Part A 2011, 17(9-10):1445-1455.
7. Beebe D.J., Mensing G.A., Walker G. Physics and applications of microfluidics in biology. Annu Rev Biomed Eng 2002, 4:261-286.
8. Bhadriraju K., Chen C.S. Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov Today 2002, 7(11):612-620.
9. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 1999, 13(14):1883-1900.
10. Bhumiratana S., Grayson W.L., Castaneda A., Rockwood D.N., Gil E.S., Kaplan D.L., et al. Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials 2011, 32(11):2812-2820.
11. Bian L., Zhai D.Y., Zhang E.C., Mauck R.L., Burdick J.A. Dynamic compressive loading enhances cartilage matrix synthesis and distribution and suppresses hypertrophy in hMSC-laden hyaluronic acid hydrogels. Tissue Eng Part A 2012, 18(7-8):715-724.
12. Braam S.R., Tertoolen L., Van de Stolpe A., Meyer T., Passier R., Mummery C.L. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010, 4(2):107-116.
13. Bradley C.K., Scott H.A., Chami O., Peura T.T., Dumevska B., Schmidt U., et al. Derivation of Huntington's disease-affected human embryonic stem cell lines. Stem Cells Dev 2011, 20(3):495-502.
14. Chahine N.O., Albro M.B., Lima E.G., Wei V.I., Dubois C.R., Hung C.T., et al. Effect of dynamic loading on the transport of solutes into agarose hydrogels. Biophys J 2009, 97(4):968-975.
15. Chamberlain S.J., Li X.J., Lalande M. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics 2008, 9(4):227-235.
16. Chang R., Nam J., Sun W. Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. Tissue Eng Part C Methods 2008, 14(2):157-166.
17. Cheshier S.H., Morrison S.J., Liao X., Weissman I.L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. PNAS 1999, 96(6):3120-3125.
18. Chung S., Sudo R., Mack P.J., Wan C.R., Vickerman V., Kamm R.D. Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip 2009, 9:269-275.
19. Cimetta E., Figallo E., Cannizzaro C., Elvassore N., Vunjak-Novakovic G. Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications. Methods 2009, 47:81-89.
20. Cimetta E., Cannizzaro C., James R., Biechele T., Moon R.T., Elvassore N., et al. Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of b-catenin signaling. Lab Chip 2010, 10:3277-3283.
21. Cimetta E., Sirabella D., Yeager K., Davidson K., Simon J., Moon R.T., Vunjak-Novakovic G. Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells. Lab Chip 2013, 13(3):355-364.
22. Colman A. Induced pluripotent stem cells and human disease. Cell Stem Cell 2008, 3(3):236-237.
23. Correia C., Grayson W.L., Park M., Hutton D., Zhou B., Guo X.E., et al. In vitro model of vascularized bone: synergizing vascular development and osteogenesis. PLoS One 2011, 6(12):e28352.
24. Dalby M.J., Gadegaard N., Tare R., Andar A., Riehle M.O., Herzyk P., et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007, 6(12):997-1003.
25. Dang S.M., Gerecht-Nir S., Chen J., Itskovitz-Eldo r.J., Zandstra P.W. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells 2004, 22(3):275-282.
26. Davis R.P., Van den Berg C.W., Casini S., Braam S.R., Mummery C.L. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med 2011, 17(9):475-484.
27. Diao J., Young L., Kim S., Fogarty E.A., Heilman S.M., Zhou P., et al. A three-channel microfluidic device for generating static linear gradients and its application to the quantitative analysis of bacterial chemotaxis. Lab Chip 2006, 6:381-388.
28. DiMasi J.A., Hansen R.W., Grabowski H.G. The price of innovation: new estimates of drug development costs. J Health Econ 2003, 22(2):151-185.
29. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321(5893):1218-1221.
30. Dittrich P.S., Manz A. Lab-on-a-chip: microfluidics in drug discovery. Nat Rev Drug Discov 2006, 5:210-218.
31. Ebert A.D., Yu J.Y., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457(7227):277-280.
32. Eiges R., Urbach A., Malcov M., Frumkin T., Schwartz T., Amit A., et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007, 1(5):568-577.
33. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126(4):677-689.
34. Ferreira L.S., Gerecht S., Fuller J., Shieh H.F., Vunjak-Novakovic G., Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007, 28(17):2706-2717.
35. Figallo E., Cannizzaro C., Gerecht S., Burdick J.A., Langer R., Elvassore N., et al. Micro-bioreactor array for controlling cellular microenvironments. Lab Chip 2007, 7:710-719.
36. Fluri D.A., Tonge P.D., Song H., Baptista R.P., Shakiba N., Shukla S., et al. Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat Methods 2012, 9(5):509-516.
37. Fok E.Y., Zandstra P.W. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 2005, 23(9):1333-1342.
38. Fröhlich M., Grayson W.L., Wan L.Q., Marolt D., Drobnic M., Vunjak-Novakovic G. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther 2008, 3(4):254-264.
39. Fröhlich M., Grayson W.L., Marolt D., Gimble J.M., Kregar-Velikonja N., Vunjak-Novakovic G. Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A 2010, 16(1):179-189.
40. Gerecht S., Burdick J.A., Ferreira L.S., Townsend S.A., Langer R., Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. PNAS 2007, 104(27):11298-11303.
41. Gerecht-Nir S., Cohen S., Itskovitz-Eldor J. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 2004, 86(5):493-502.
42. Ghanem A., Shuler M.L. Characterization of a perfusion reactor utilizing mammalian cells on microcarrier beads. Biotechnol Prog 2000, 16(3):471-479.
43. Ghanem A., Shuler M.L. Combining cell culture analogue reactor designs and PBPK models to probe mechanisms of naphthalene toxicity. Biotechnol Prog 2000, 16(3):334-345.
44. Gilbert P.M., Havenstrite K.L., Magnusson K.E., Sacco A., Leonardi N.A., Kraft P., et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 2010, 329(5995):1078-1081.
45. Giudice A., Trounson A. Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell 2008, 2(5):422-433.
46. Gobaa S., Hoehnel S., Roccio M., Negro A., Kobel S., Lutolf M.P. Artificial niche microarrays for probing single stem cell fate in high throughput. Nat Methods 2011, 8(11):949-955.
47. Goldring C.E., Duffy P.A., Benvenisty N., Andrews P.W., Ben-David U., Eakins R., et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell 2011, 8(6):618-628.
48. Gomez-Sjoberg R., Leyrat A.A., Pirone D.M., Chen C.S., Quake S.R. Versatile, fully automated, microfluidic cell culture system. Anal Chem 2007, 79(22):8557-8563.
49. Grayson W.L., Bhumiratana S., Cannizzaro C., Chao P.H., Lennon D.P., Caplan A.I., et al. Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A 2008, 14(11):1809-1820.
50. Grayson W.L., Marolt D., Bhumiratana S., Fröhlich M., Guo X.E., Vunjak-Novakovic G. Engineering custom-designed osteochondral tissue grafts. Trends Biotechnol 2008, 26(4):181-189.
51. Grayson W.L., Fröhlich M., Yeager K., Bhumiratana S., Chan M.E., Cannizzaro C., et al. Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A 2010, 107(8):3299-3304.
52. Grayson W.L., Marolt D., Bhumiratana S., Fröhlich M., Guo X.E., Vunjak-Novakovic G. Optimizing the medium perfusion rate in bone tissue engineering bioreactors. Biotechnol Bioeng 2011, 108(5):1159-1170.
53. Hanjaya-Putra D., Bose V., Shen Y.I., Yee J., Khetan S., Fox-Talbot K., et al. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 2011, 118(3):804-815.
54. Hofmann S., Hagenmüller H., Koch A.M., Müller R., Vunjak-Novakovic G., Kaplan D.L., et al. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 2007, 28(6):1152-1162.
55. Huh D., Torisawa Y.S., Hamilton G.A., Kim H.J., Ingber D.E. Microengineered physiological biomimicry: organs-on-chips. Lab Chip 2012, 12(12):2156-2164.
56. Israel M., Yuan S., Bardy C., Reyna S., Mu Y., Herrera C., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482(7384):216-220.
57. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000, 6(2):88-95.
58. Jeon N.L., Dertinger S.K.W., Chiu D.T., Choi I.S., Stroock A.D., Whitesides G.M. Generation of solution and surface gradients using microfluidic systems. Langmuir 2000, 16:8311-8316.
59. Jing D., Parikh A., Tzanakakis E.S. Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplant 2010, 19(11):1397-1412.
60. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238(1):265-272.
61. Kane R.S., Takayama S., Ostuni E., Ingber D.E., Whitesides G.M. Patterning proteins and cells using soft lithography. Biomaterials 1999, 20:2363-2376.
62. Kaplan D., Moon R.T., Vunjak-Novakovic G. It takes a village to grow a tissue. Nat Biotechnol 2005, 23(10):1237-1239.
63. Kattman S.J., Huber T.L., Keller G.M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006, 11(5):723-732.
64. Kehoe D.E., Jing D., Lock L.T., Tzanakakis E.S. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A 2010, 16(2):405-421.
65. Kensah G., Gruh I., Viering J., Schumann H., Dahlmann J., Meyer H., et al. A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Eng Part C Methods 2011, 17(4):463-473.
66. Khetani S.R., Bhatia S.N. Microscale culture of human liver cells for drug development. Nat Biotechnol 2008, 26(1):120-126.
67. Khetani S.R., Szulgit G., Del Rio J.A., Barlow C., Bhatia S.N. Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling. Hepatology 2004, 40(3):545-554.
68. Kim H.J., Huh D., Hamilton G., Ingber D.E. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 2012, 12(12):2165-2174.
69. Kola I. The state of innovation in drug development. Clin Pharmacol Ther 2008, 83(2):227-230.
70. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov 2004, 3(8):711-716.
71. Kraehenbuehl T.P., Langer R., Ferreira L.S. Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods 2011, 8(9):731-736.
72. Krawetz R., Taiani J.T., Liu S., Meng G., Li X., Kallos M.S., et al. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods 2010, 16(4):573-582.
73. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260(5110):920-926.
74. Lecault V., Vaninsberghe M., Sekulovic S., Knapp D.J., Wohrer S., Bowden W., et al. High-throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arrays. Nat Methods 2011, 8(7):581-586.
75. Lee G., Studer L. Modelling familial dysautonomia in human induced pluripotent stem cells. Philos Trans R Soc Lond B Biol Sci 2011, 366(1575):2286-2296.
76. Li A.P. Accurate prediction of human drug toxicity: a major challenge in drug development. Chem Biol Interact 2004, 150(1):3-7.
77. Li A.P. In vitro evaluation of human xenobiotic toxicity: scientific concepts and the novel integrated discrete multiple cell co-culture (IdMOC) technology. ALTEX 2008, 25(1):43-49.
78. Li A.P., Bode C., Sakai Y. A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem Biol Interact 2004, 150(1):129-136.
79. Lloyd K.C. A knockout mouse resource for the biomedical research community. Ann N Y Acad Sci 2011, 1245:24-26.
80. Lock L.T., Tzanakakis E.S. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A 2009, 15(8):2051-2063.
81. Lutolf M.P., Hubbel J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23(1):47-55.
82. Ma B., Zhang G., Qin J., Lin B. Characterization of drug metabolites and cytotoxicity assay simultaneously using an integrated microfluidic device. Lab Chip 2009, 9(2):232-238.
83. Maidhof R., Tandon N., Lee E.J., Luo J., Duan Y., Yeager K., et al. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J Tissue Eng Regen Med 2012, 6(10):e12-e23.
84. Marolt D., Augst A., Freed L.E., Vepari C., Fajardo R., Patel N., et al. Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors. Biomaterials 2006, 27(36):6138-6149.
85. Marolt D., Campos I.M., Bhumiratana S., Koren A., Petridis P., Zhang G., et al. Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A 2012, 109(22):8705-8709.
86. Martin Y., Vermette P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 2005, 26(35):7481-7503.
87. Mateizel I., De Temmerman N., Ullmann U., Cauffman G., Sermon K., Van de Velde H., et al. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 2006, 21(2):503-511.
88. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004, 6(4):483-495.
89. McCreedy T. Fabrication techniques and materials commonly used for the production of microreactors and micro total analytical systems. Trends Anal Chem 2000, 19(6):396-401.
90. McDonald J.C., Duffy D.C., Anderson J.R., Chiu D.T., Wu H.K., Schueller O.J.A., et al. Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 2000, 21(1):27-40.
91. Montserrat N., De Oñate L., Garreta E., González F., Adamo A., Eguizábal C., et al. Generation of feeder free pig induced pluripotent stem cells without Pou5f1. Cell Transplant 2012, 21(5):815-825.
92. Nie Y., Bergendahl V., Hei D.J., Jones J.M., Palecek S.P. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog 2009, 25(1):20-31.
93. Niebruegge S., Bauwens C.L., Peerani R., Thavandiran N., Masse S., Sevaptisidis E., et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 2009, 102(2):493-507.
94. Nishikawa S., Goldstein R.A., Nierras C.R. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008, 9(9):725-729.
95. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134(5):877-886.
96. Pickering S.J., Minger S.L., Patel M., Taylor H., Black C., Burns C.J., et al. Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod Biomed Online 2005, 10(3):390-397.
97. Pouton C.W., Haynes J.M. Pharmaceutical applications of embryonic stem cells. Adv Drug Deliv Rev 2005, 57(13):1918-1934.
98. Pouton C.W., Haynes J.M. Embryonic stem cells as a source of models for drug discovery. Nat Rev Endocrinol 2007, 6(8):605-616.
99. Report Top R&D drug failures - toxicity and serious adverse events in late stage drug development are the major causes of drug failure 2011, Global Business Intelligence Research.
100. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255(5052):1707-1710.
101. Richards-Grayson A.C., Shawgo R.S., Johnoson A.M., Flynn N.T., Li Y., Cima M.J., et al. A BioMEMS review: MEMS technology for physiologically integrated devices. Proc IEEE 2004, 92(1):6-21.
102. Rolletschek A., Wobus A.M. Induced human pluripotent stem cells: promises and open questions. Biol Chem 2009, 390(9):845-849.
103. Rolletschek A., Blyszczuk P., Wobus A.M. Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol Lett 2004, 149:361-369.
104. Sacco A., Mourkioti F., Tran R., Choi J., Llewellyn M., Kraft P., et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143(7):1059-1071.
105. Salter E., Goh B., Hung B., Hutton D., Ghone N., Grayson W.L. Bone tissue engineering bioreactors: a role in the clinic?. Tissue Eng Part B Rev 2012, 18(1):62-75.
106. Sargent C.Y., Berguig G.Y., Kinney M.A., Hiatt L.A., Carpenedo R.L., Berson R.E., et al. Hydrodynamic modulation of embryonic stem cell differentiation by rotary orbital suspension culture. Biotechnol Bioeng 2010, 105(3):611-626.
107. Schimming R., Schmelzeisen R. Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg 2004, 62(6):724-729.
108. Shafa M., Day B., Yamashita A., Meng G., Liu S., Krawetz R., et al. Derivation of iPSCs in stirred suspension bioreactors. Nat Methods 2012, 9:465-466.
109. Shin H., Zygourakis K., Farach-Carson M.C., Yaszemski M.J., Mikos A.G. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A 2004, 69(3):535-543.
110. Shultz L.D., Brehm M.A., Bavari S., Greiner D.L. Humanized mice as a preclinical tool for infectious disease and biomedical research. Ann N Y Acad Sci 2011, 1245:50-54.
111. Sikavitsas V.I., Bancroft G.N., Holtorf H.L., Jansen J.A., Mikos A.G. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. PNAS 2003, 100(25):14683-14688.
112. Sin A., Chin K.C., Jamil M.F., Kostov Y., Rao G., Shuler M.L. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol Prog 2004, 20(1):338-345.
113. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G., Cook E., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 6(136):964-977.
114. Son J.S., Kim S.G., Oh J.S., Appleford M., Oh S., Ong J.L., et al. Hydroxyapatite/polylactide biphasic combination scaffold loaded with dexamethasone for bone regeneration. J Biomed Mater Res A 2011, 99(4):638-647.
115. Squires T.M., Quake S.R. Microfluidics: fluid physics at the nanoliter scale. Rev Mod Phys 2005, 77:977-1016.
116. Steiner D., Khaner H., Cohen M., Even-Ram S., Gil Y., Itsykson P., et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol 2010, 28(4):361-364.
117. Sweeney L.M., Shuler M.L., Babish J.G., Ghanem A. A cell culture analogue of rodent physiology: application to naphthalene toxicology. Toxicol In Vitro 1995, 9(3):307-316.
118. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
119. Takayama G., Taniguchi A., Okano T. Identification of differentially expressed genes in hepatocyte/endothelial cell co-culture system. Tissue Eng 2007, 13:159-166.
120. Tandon N., Marsano A., Maidhof R., Numata K., Montouri-Sorrentino C., Cannizzaro C., et al. Surface-patterned electrode bioreactor for electrical stimulation. Lab Chip 2010, 10(6):692-700.
121. Tatosian D.A., Shuler M.L. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers. Biotechnol Bioeng 2009, 103(1):187-198.
122. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
123. Toetsch S., Olwell P., Prina-Mello A., Volkov Y. The evolution of chemotaxis assays from static models to physiologically relevant platforms. Integr Biol 2009, 1:170-181.
124. Toner M., Irimia D. Blood-on-a-chip. Annu Rev Biomed Eng 2005, 7:77-103.
125. Tran R.T., Thevenot P., Zhang Y., Gyawali D., Tang L., Yang J. Scaffold sheet design strategy for soft tissue engineering. Nat Mater 2010, 3(2):1375-1389.
126. Unternaehrer J.J., Daley G.Q. Induced pluripotent stem cells for modelling human diseases. Philos Trans R Soc London, Ser B 2011, 366:2274-2285.
127. Viravaidya K., Shuler M.L. Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol Prog 2004, 20(2):590-597.
128. Viravaidya K., Sin A., Shuler M.L. Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol Prog 2004, 20(1):316-323.
129. Vozzi F., Heinrich J.M., Bader A., Ahluwalia A.D. Connected culture of murine hepatocytes and HUVEC in a multicompartmental bioreactor. Tissue Eng Part A 2009, 15(6):1291-1299.
130. Vozzi F., Mazzei D., Vinci B., Vozzi G., Sbrana T., Ricotti L., et al. A flexible bioreactor system for constructing in vitro tissue and organ models. Biotechnol Bioeng 2011, 108(9):2129-2140.
131. Vunjak-Novakovic G., Meinel L., Altman G., Kaplan D. Bioreactor cultivation of osteochondral grafts. Orthod Craniofac Res 2005, 8(3):209-218.
132. Wang F., Li Z., Tamama K., Sen C.K., Guan J. Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation. Biomacromolecules 2009, 10(9):2609-2618.
133. Wang W.W.W., Khetani S.R., Krzyzewski S., Duignan D.B., Obach R.S. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Drug Metab Dispos 2010, 38(10):1900-1905.
134. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007, 25(6):681-686.
135. Wen Y., Yang S.T. The future of microfluidic assays in drug development. Expert Opin Drug Discovery 2008, 3(10):1237-1253.
136. Whitesides G.M., Ostuni E., Takayama S., Jiang X., Ingber D.E. Soft lithography in biology and biochemistry. Annu Rev Biomed Eng 2001, 3:335-373.
137. Wobus A.M., Loser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol 2011, 85(2):79-117.
138. Xia Y., Whitesides G.M. Soft lithography. Annu Rev Mater Sci 1998, 28:153-184.
139. Ye N., Qin J., Shi W., Liu X., Lin B. Cell-based high content screening using an integrated microfluidic device. Lab Chip 2007, 7(12):1696-1704.
140. Zhang C., Zhao Z., Abdul Rahim N.A., van Noort D., Yu H. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 2009, 9(22):3185-3192.
141. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009, 104(4):e30-e41.